Kenji Sugata

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy

Yuki Kagoya, Tingxi Guo, Brian Yeung et al. · Cancer Immunology Research · 2020 · 176 citations

Life Sciences, Immunology, Oncology +17

HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator

Tiejun Zhao, Yorifumi Satou, Kenji Sugata et al. · Blood · 2011 · 147 citations · Full text

Life Sciences, Genetics, Molecular Biology +4

Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo

Rie Furuta, Jun‐ichirou Yasunaga, Michi Miura et al. · PLoS Pathogens · 2017 · 84 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)

Keiko Yasuma-Mitobe, Jun‐ichirou Yasunaga, Keiko Takemoto et al. · PLoS Pathogens · 2016 · 83 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor

Kenji Sugata, Jun‐ichirou Yasunaga, Yuichi Mitobe et al. · Blood · 2015 · 78 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16